ripekg:evaluation/RIPEAF8D7B98E670B0858 |
rdf:type |
rdfs:Resource |
ripekg:evaluation/RIPEAF8D7B98E670B0858 |
rdf:type |
owl:Thing |
ripekg:evaluation/RIPEAF8D7B98E670B0858 |
rdf:type |
tido:Evaluation |
ripekg:evaluation/RIPEAF8D7B98E670B0858 |
prov:endedAtTime |
2025-11-12T16:59:41.331865Z |
ripekg:evaluation/RIPEAF8D7B98E670B0858 |
prov:startedAtTime |
2025-11-12T16:54:47.887000Z |
ripekg:evaluation/RIPEAF8D7B98E670B0858 |
prov:used |
ripekg:expression-of-concern/31203Vaginal progesterone for prevention of preterm labor in asymptomatic twin pregnancies with sonographic short cervix: a randomized clinical trial of efficacy and safety |
ripekg:evaluation/RIPEAF8D7B98E670B0858 |
prov:used |
ripekg:peer-comment/RIPEAF8D7B98E670B0858-1 |
ripekg:evaluation/RIPEAF8D7B98E670B0858 |
prov:used |
ripekg:publication-details/RIPEAF8D7B98E670B0858RETRACTED ARTICLE: Vaginal progesterone for prevention of preterm labor in asymptomatic twin pregnancies with sonographic short cervix: a randomized clinical trial of efficacy and safety |
ripekg:evaluation/RIPEAF8D7B98E670B0858 |
prov:used |
ripekg:registry-evidence/RIPEAF8D7B98E670B0858 |
ripekg:evaluation/RIPEAF8D7B98E670B0858 |
prov:used |
ripekg:retraction-notice/31202Vaginal progesterone for prevention of preterm labor in asymptomatic twin pregnancies with sonographic short cervix: a randomized clinical trial of efficacy and safety |
ripekg:evaluation/RIPEAF8D7B98E670B0858 |
prov:used |
ripekg:retraction-notice/31203Vaginal progesterone for prevention of preterm labor in asymptomatic twin pregnancies with sonographic short cervix: a randomized clinical trial of efficacy and safety |
ripekg:evaluation/RIPEAF8D7B98E670B0858 |
prov:used |
ripekg:retraction-notice/40512Laparoscopy - or not - for management of unexplained infertility |
ripekg:evaluation/RIPEAF8D7B98E670B0858 |
prov:used |
ripekg:retraction-notice/40545Low-molecular weight heparin in patients with recurrent early miscarriages of unknown aetiology |
ripekg:evaluation/RIPEAF8D7B98E670B0858 |
prov:used |
ripekg:retraction-notice/43617Does laparoscopic ovarian diathermy change clomiphene-resistant PCOS into clomiphene-sensitive |
ripekg:evaluation/RIPEAF8D7B98E670B0858 |
prov:used |
ripekg:retraction-notice/43882Letrozole versus laparoscopic ovarian diathermy for ovulation induction in clomiphene-resistant women with polycystic ovary syndrome: a randomized controlled trial |
ripekg:evaluation/RIPEAF8D7B98E670B0858 |
prov:used |
ripekg:retraction-notice/46284Clomiphene citrate plus N-acetyl cysteine versus clomiphene citrate for augmenting ovulation in the management of unexplained infertility: a randomized double-blind controlled trial |
ripekg:evaluation/RIPEAF8D7B98E670B0858 |
prov:used |
ripekg:retraction-notice/46287Clomiphene citrate or anastrozole for ovulation induction in women with polycystic ovary syndrome? A prospective controlled trial |
ripekg:evaluation/RIPEAF8D7B98E670B0858 |
prov:used |
ripekg:retraction-notice/46289Effect of sperm morphology and number on success of intrauterine insemination |
ripekg:evaluation/RIPEAF8D7B98E670B0858 |
prov:used |
ripekg:retraction-notice/46290Luteal phase clomiphene citrate for ovulation induction in women with polycystic ovary syndrome: a novel protocol |
ripekg:evaluation/RIPEAF8D7B98E670B0858 |
prov:used |
ripekg:retraction-notice/46292Ultrasound-guided transvaginal ovarian needle drilling (UTND) for treatment of polycystic ovary syndrome: a randomized controlled trial |
ripekg:evaluation/RIPEAF8D7B98E670B0858 |
prov:used |
ripekg:retraction-notice/46293Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study |
ripekg:evaluation/RIPEAF8D7B98E670B0858 |
prov:used |
ripekg:retraction-notice/46294Extended letrozole therapy for ovulation induction in clomiphene-resistant women with polycystic ovary syndrome: a novel protocol |
ripekg:evaluation/RIPEAF8D7B98E670B0858 |
prov:used |
ripekg:retraction-notice/47511Induction of ovulation in idiopathic premature ovarian failure: a randomized double-blind trial |
ripekg:evaluation/RIPEAF8D7B98E670B0858 |
prov:used |
ripekg:retraction-notice/47512Randomized controlled trial of three doses of letrozole for ovulation induction in patients with unexplained infertility |
ripekg:evaluation/RIPEAF8D7B98E670B0858 |
prov:used |
ripekg:retraction-notice/47513Extending clomiphene treatment in clomiphene-resistant women with PCOS: a randomized controlled trial |
ripekg:evaluation/RIPEAF8D7B98E670B0858 |
prov:used |
ripekg:retraction-notice/48487Accelerated Coasting Does Not Affect Oocyte Maturation |
ripekg:evaluation/RIPEAF8D7B98E670B0858 |
prov:used |
ripekg:retraction-notice/51879Clomiphene citrate or aromatase inhibitors combined with gonadotropins for superovulation in women undergoing intrauterine insemination: A prospective randomised trial |
ripekg:evaluation/RIPEAF8D7B98E670B0858 |
prov:used |
ripekg:retraction-notice/51923Can flowcytometric DNA studies forecast the prognosis of endometrial hyperplasia? |
ripekg:evaluation/RIPEAF8D7B98E670B0858 |
prov:used |
ripekg:retraction-notice/51938Subfertility treatment in women with systemic lupus erythematosus |
ripekg:evaluation/RIPEAF8D7B98E670B0858 |
prov:used |
ripekg:retraction-notice/53778Combined coenzyme Q10 and clomiphene citrate for ovulation induction in clomiphene-citrate-resistant polycystic ovary syndrome |
ripekg:evaluation/RIPEAF8D7B98E670B0858 |
prov:used |
ripekg:retraction-notice/53779Combined coenzyme Q10 and clomiphene citrate for ovulation induction in clomiphene-citrate-resistant polycystic ovary syndrome |
ripekg:evaluation/RIPEAF8D7B98E670B0858 |
prov:used |
ripekg:study-design-evidence/RIPEAF8D7B98E670B0858 |
ripekg:evaluation/RIPEAF8D7B98E670B0858 |
prov:wasAssociatedWith |
ripekg:automated-agent/inspect-ai/1.0.0INSPECT-AI 1.0.0 |
ripekg:evaluation/RIPEAF8D7B98E670B0858 |
prov:wasAssociatedWith |
ripekg:automated-agent/inspect-ai/1.0.0INSPECT-AI |
ripekg:evaluation/RIPEAF8D7B98E670B0858 |
prov:wasAssociatedWith |
ripekg:human-reviewer/RV013 |
ripekg:evaluation/RIPEAF8D7B98E670B0858 |
prov:wasInformedBy |
ripekg:evidence-aggregation/RIPEAF8D7B98E670B0858 |
ripekg:evaluation/RIPEAF8D7B98E670B0858 |
tido:contributesTo |
ripekg:research-integrity-assessment/RIPEAF8D7B98E670B0858 |
ripekg:integrity-assessment-hypothesis/RIPEAF8D7B98E670B0858-human-1-1 |
prov:wasGeneratedBy |
ripekg:evaluation/RIPEAF8D7B98E670B0858 |
ripekg:integrity-assessment-hypothesis/RIPEAF8D7B98E670B0858-human-1-2 |
prov:wasGeneratedBy |
ripekg:evaluation/RIPEAF8D7B98E670B0858 |
ripekg:integrity-assessment-hypothesis/RIPEAF8D7B98E670B0858-human-1-3 |
prov:wasGeneratedBy |
ripekg:evaluation/RIPEAF8D7B98E670B0858 |
ripekg:integrity-assessment-hypothesis/RIPEAF8D7B98E670B0858-human-2-2 |
prov:wasGeneratedBy |
ripekg:evaluation/RIPEAF8D7B98E670B0858 |
ripekg:integrity-assessment-hypothesis/RIPEAF8D7B98E670B0858-human-overall |
prov:wasGeneratedBy |
ripekg:evaluation/RIPEAF8D7B98E670B0858 |
ripekg:integrity-assessment-hypothesis/RIPEAF8D7B98E670B0858-inspectai-1-1 |
prov:wasGeneratedBy |
ripekg:evaluation/RIPEAF8D7B98E670B0858 |
ripekg:integrity-assessment-hypothesis/RIPEAF8D7B98E670B0858-inspectai-1-2 |
prov:wasGeneratedBy |
ripekg:evaluation/RIPEAF8D7B98E670B0858 |
ripekg:integrity-assessment-hypothesis/RIPEAF8D7B98E670B0858-inspectai-1-3 |
prov:wasGeneratedBy |
ripekg:evaluation/RIPEAF8D7B98E670B0858 |
ripekg:integrity-assessment-hypothesis/RIPEAF8D7B98E670B0858-inspectai-2-2 |
prov:wasGeneratedBy |
ripekg:evaluation/RIPEAF8D7B98E670B0858 |
ripekg:integrity-assessment-hypothesis/RIPEAF8D7B98E670B0858-inspectai-overall |
prov:wasGeneratedBy |
ripekg:evaluation/RIPEAF8D7B98E670B0858 |